Bridgewater Associates’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.73M Buy
+521,546
New +$3.73M 0.03% 455

Other funds holding IOVA

Bridgewater Associates's IOVA Position: Q3 2026 in Review

Bridgewater Associates opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2026: 521,546 shares worth $7.73M. The stake represents 0.03% of the portfolio and ranks #455 among its holdings.

335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • Bridgewater Associates held 521,546 shares of Iovance Biotherapeutics worth $7.73M as of Q3 2026.
  • Iovance Biotherapeutics was a new Bridgewater Associates position in Q3 2026.
  • Iovance Biotherapeutics made up 0.03% of Bridgewater Associates's portfolio in Q3 2026, its #455 holding.
  • 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on Bridgewater Associates's 13F filing for Q3 2026, filed 16 Nov 2026.